HCC typically manifests in patients with viral hepatitis or cirrhotic backgrounds, accompanied by elevated AFP levels, intense arterial-phase hyperenhancement, and subsequent portal/equilibrium-phase contrast washout. Here, AFP is linked to hepatocellular carcinoma.